[ad_1]

Pune, India, July 25, 2022 (GLOBE NEWSWIRE) — The Global “Microcarrier Market Share” is expected to grow due to the rising requirements for efficient vaccines during the forecast period. Fortune Business Insights™ publishes this information in an upcoming report titled, “Microcarrier Market, 2021-2028″.

Microcarriers as considered as a support matrix for adherent cell growth. There are placed in a bioreactor to increase the growth of the cells. The increasing burden of various diseases globally is likely to boost the market in the coming years. Demand for therapeutically effective microcarriers is emerging in the R&D and pharmaceutical sectors.

Key Industry Development

November 2020: Singapore-MIT alliance for research and technology introduced gelatin-based microcarrier for cell production.   

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/microcarrier-market-105135

Report Coverage:

The market report developed on microcarriers focuses on new product launches introduced by the key players in the market. The impact of COVID-19 on the global market is assessed further in the report to showcase potential opportunities for market expansion. Evidence of investments in cell biology research, gene therapy, and vaccine production is provided to clarify the market analysis better. Also, advancements in the market are highlighted to evaluate the latest trends and developments in the industry. Strategies adopted by key players such as mergers, acquisitions, and partnerships are highlighted further in this report. The report focuses on providing factual data regarding the market analysis.  

Market Growth Drivers

Rising Demands for Therapeutically Efficient Vaccine to Stimulate Market Growth

The global microcarrier market growth is expected to develop during the forecast period due to the increasing demands for efficient vaccines and drugs. Increasing demands for therapeutically efficient vaccines are expected to drive the market. The rising prevalence of various diseases is likely to enhance product demand for appropriate treatments. In contrast, high investments required for cell biology research are likely to hinder market growth. 

Click here to get the short-term and long-term impact of COVID-19 on this Market:

https://www.fortunebusinessinsights.com/microcarrier-market-105135

Market Segmentations

By product, the market is bifurcated into microcarrier equipment and consumables such as reagents and media.

On the basis of application, the market is divided into cell & gene therapy, biopharmaceutical production (vaccine drugs), and others (Regenerative medicines).

Based on the end-users, the market is trifurcated into academic & research institutes, pharmaceuticals & biotechnology companies, and others.

Finally, by geography, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

              Segmentation By Product

  • Microcarrier Equipment
  • Consumables (Reagents, Media)
By Application

  • Cell & Gene Therapy
  • Biopharmaceutical Production (Vaccine, Drugs)
  • Others (Regenerative medicines)
By End user

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others
By Geography

  • North America (USA, Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Competitive Landscape

Product Development Strategies Allows Key Players to Maintain Market Position

The presence of major key players in the market focuses on preserving their positions to gain a competitive advantage. Increasing R&D and innovation management activities investments are likely to support market growth. Forming strategic alliances and supporting organizations allows competitors to expand their business reach.    

Pre Book – Microcarrier Market:

https://www.fortunebusinessinsights.com/checkout-page/105135

Regional Analysis

North America Dominates Market by Investing Into R&D Activities

  • North America is expected to hold the most prominent global microcarrier market size in the coming years. Increasing R&D activities for cell and gene therapies to develop the vaccines required bolsters market growth. The increasing demand for vaccines in pandemic periods allows the segmented region to dominate the global market.
  • Europe is the second-largest region to hold the global market position. The rising adoption of technological advancements allows the key players to control the market position. Increasing utilization of R&D activities is likely to boost product development and demands in the market.  

List of Key Players Profiled in the Global Market Report for Microcarrier:

  • Cytiva (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • Sigma Aldrich (U.S.)
  • Corning Incorporated (U.S.)
  • Merck Inc. (U.S.)
  • Eppendorf AG (Germany)
  • Sartorius AG (Germany)
  • Himedia Laboratories (India)

Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/queries/microcarrier-market-105135

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com


[ad_2]

Source link